53 Coakley JH, Nagendran K, Ormerod IE, Ferguson CN, Hinds CJ. Prolonged neurogenic weakness in patients requiring mechanical ventilation for acute airflow limitation. Chest 1992; 101: 1413-16.
54 Bott J, Carroll MP, Conway JH etal. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993; 341: 1555-7.
55 Brochard L, Mancebo J, Wysocki M etal. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333: 817-22.
56 Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995; 151: 1799-806.
57 Barbe F, Togores B, Rubi M et al. Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease. Eur Respir J1996; 9: 1240-5.
58 Plant PK, Owen J, Elliott MW. One year period prevalence study of respiratory acidosis in acute exacerbation of COPD: implications for the provision of non-invasive ventilation and oxygen administration. Thorax 2000; 55: 550-4.
59 Plant PK, Owen JL, Elliott MW. A multicentre randomised controlled trial of the early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards. Lancet 2000; 355: 1931-5.
60 Plant PK, Owen JL, Elliott MW. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome. Thorax 2001; 56: 708-12.
61 Grassino A, Comtois N, Galdiz HJ, Sinderby C. The unweanable patient. Monaldi Arch Chest Dis 1994; 49: 522-6.
62 Udwadia ZF, Santis GK, Steven MH, Simonds AK. Nasal ventilation to facilitate weaning in patients with chronic respiratory insufficiency. Thorax 1992; 47: 715-18.
63 Restrick LJ, Scott AD, Ward EM et al. Nasal intermittent positive-pressure ventilation in weaning intubated patients with chronic respiratory disease from assisted positive-pressure ventilation. Respir Med 1993; 87: 199-204.
64 Nava S, Ambrosino N, Clini E et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease: a randomized, controlled trial. Ann Intern Med 1998; 128: 721-8.
65 Girault C, Daudenthun I, Chevron V et al. Noninvasive ventilation as a systematic extubation and weaning technique in acute-on-chronic respiratory failure: a prospective, randomized controlled study. Am J Respir Crit Care Med 1999; 160: 86-92.
66 Hilbert G, Gruson D, Porel L et al. Noninvasive pressure support ventilation in COPD patients with post extubation hypercapnic respiratory insufficiency. Eur Respir J1998; 11: 1349-53.
67 Corrado A, Bruscoli G, Messori A et al. Iron lung treatment of subjects with COPD in acute respiratory failure: evaluation of short- and long-term prognosis. Chest 1992; 101: 692-6.
68 Corrado A, De Paola E, Gorini M et al. Intermittent negative pressure ventilation in the treatment of hypoxic hypercapnic coma in chronic respiratory insufficiency. Thorax 1996; 51: 1077-82.
69 Elliott MW. Noninvasive ventilation in chronic obstructive pulmonary disease. N Engl J Med 1995; 333: 870-1.
70 Baldwin DR, Allen MB. Non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. BMJ 1997; 314: 163-4.
71 Ambrosino N, Foglio K, Rubini F et al. Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive airways disease: correlates for success. Thorax 1995; 50: 755-7.
72 Meduri GU, Turner RE, Abou-Shala N, Wunderink R, Tolley E. Noninvasive positive pressure ventilation via face mask: first-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure. Chest 1996; 109: 179-93.
73 Soo Hoo GW, Santiago S, Williams AJ. Nasal mechanical ventilation for hypercapnic respiratory failure in chronic obstructive pulmonary disease. determinants of success and failure. Crit Care Med 1994; 22: 1253-61.
74 Ambrosino N. Noninvasive mechanical ventilation in acute on chronic respiratory failure: determinants of success and failure. Monaldi Arch Chest Dis 1997; 52: 73-5.
75 Hill AT, Hopkinson RB, Stableforth DE. Ventilation in a Birmingham intensive care unit, 1993-95: outcome for patients with chronic obstructive pulmonary disease. Respir Med 1998; 92: 156-61.
76 Pearlman RA. Variability in physician estimates of survival for acute respiratory failure in chronic obstructive pulmonary disease. Chest 1987; 91: 515-21.
77 Kaelin RM, Assimacopoulos A, Chevrolet JC. Failure to predict six-month survival of patients with COPD requiring mechanical ventilation by analysis of simple indices: a prospective study. Chest 1987; 92: 971-8.
78 Stauffer JL, Fayter NA, Graves B et al. Survival following mechanical ventilation for acute respiratory failure in adult men. Chest 1993; 104: 1222-9.
79 Nava S, Rubini F, Zanotti E et al. Survival and prediction of successful ventilator weaning in COPD patients requiring mechanical ventilation for more than 21 days. Eur Respir J1994; 7: 1645-52.
80 Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu J. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation: a 10-year analysis of ANTADIR observatory. Chest 1996; 109: 741-9.
81 Deber RB. Physicians in health care management, 7: the patient-physician partnership—changing roles and the desire for information. Can Med Assoc J 1994; 151: 171-6.
82 Denger LF, Sloan JA. Decision making during illness: what role do patients really want to play? J Clin Epidemiol 1992; 45: 941.
83 Sullivan KE, Hebert PC, Logan J, O'Connor AM, McNeely PD. What do physicians tell patients with end-stage COPD about intubation and mechanical ventilation? Chest 1996; 109: 258-64.
84 American Thoracic Society. Withholding and withdrawing life sustaining therapy. Ann Intern Med 1991; 115: 478-85.
85 Nommos D, Dubler N. Ethics on Call: Taking Charge of Life and Death Choices in Today's Health Care System. New York: Random House, 1993.
86 Uhlmann RF, Peralman RA, Cain KC. Physicians and spouses predictions of elderly patients resuscitation preferences. J Gerontol 1988; 43: 115-21.
87 Pearlman RA, Jonsen A. The use of quality-of-life considerations in medical decision making. J Am Geriatr Soc 1985; 33:344-52.
88 Asai A, Fukuhara S, Inoshita O et al. Medical decisions concerning the end of life: a discussion with Japanese physicians. J Med Ethics 1997; 23: 323-7.
89 Prendergast TJ, Claessens MT, Luce JM. A national survey of the end-of-life care for critically ill patients. Am J Respir Crit Care Med 1998; 158: 1163-7.
90 Hanson LC, Rodgman E. The use of living wills at the end of life: a national study. Arch Intern Med 1996; 13: 1018-22.
91 Malloy TR, Wigton RS, Meeske J, Tape TG. The influence of treatment descriptions on advance medical directive decisions. J Am Geriatr Soc 1992; 40: 1255-60.
92 McNeely PD, Hebert PC, Dales REO et al. Deciding about mechanical ventilation in end-stage chronic obstructive pulmonary disease: how respirologists perceive their role. Can Med Assoc J1997; 156: 177-83.
93 Ewer MS, Taubert JK. Advance directives in the intensive care unit of a tertiary cancer centre. Cancer 1995; 76: 1268-74.
94 Meduri GU, Fox RC, Abou-Shala N, Leeper KV, Wunderink R. Noninvasive mechanical ventilation via face mask in patients with acute respiratory failure who refused endotracheal intubation. Crit Care Med 1994; 22: 1584-90.
95 Adler DC. The ethics of technology. Chest 1986; 5: 765-6.
96 Chevrolet JC, Jolliet P. Workload on non-invasive ventilation in acute respiratory failure. In: Vincent JL, ed.
Yearbook of Intensive and Emergency Medicine. Berlin: Springer, 1997: 505-13.
97 Nava S, Evangelisti I, Rampulla C et al. Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failure. Chest 1997; 111: 1631-8.
98 Vitacca M, Clini E, Porta R, Sereni D, Ambrosino N. Experience of an intermediate respiratory intensive therapy in the treatment of prolonged weaning from mechanical ventilation. Minerva Anestesiol 1996; 62: 57-64.
99 Anderer W, Kunzle C, Dhein Y, Worth H. [Noninvasive ventilation in the acute care hospital: a cost factor?]. Med Klin 1997; 92 (Suppl. 1): 119-22.
100 Criner GJ, Kreimer DT, Tomaselli M, Pierson W, Evans D. Financial implications of noninvasive positive pressure ventilation (NPPV). Chest 1995; 108: 475-81.
101 Plant PK, Owen J, Elliott MW. A cost effectiveness analysis of non-invasive ventilation (NIV) in acute exacerbations of COPD [abstract]. Thorax 1999; 54 (Suppl. 3): A11.
102 Servera E, Perez M, Marin J, Vergera P, Castano R. Noninvasive nasal mask ventilation beyond the ICU for an exacerbation of chronic respiratory insufficiency. Chest 1995; 108: 1572-6.
103 Elliott MW, Baudouin SV. Respiratory intensive care in Europe: lessons for the UK. Thorax 1998; 53: 725-6.
104 Nava S, Confalonieri M, Rampulla C. Intermediate respiratory intensive care units in Europe: a European perspective. Thorax 1998; 53: 798-802.
105 Parikh CR, Karnad DR. Quality, cost, and outcome of intensive care in a public hospital in Bombay, India. Crit Care Med 1999; 27: 1754-9.
106 Appendini L, Purro A, Patessio A et al. Partitioning of inspiratory muscle workload and pressure assistance in ventilator-dependent COPD patients. Am J Respir Crit Care Med 1996; 154: 1301-9.
107 Kerr HD. Doxapram in hypercapnic chronic obstructive pulmonary disease with respiratory failure. J Emerg Med 1997; 15: 513-15.
108 Hirshberg AJ, Dupper RL. Use of doxapram hydrochloride injection as an alternative to intubation to treat chronic obstructive pulmonary disease patients with hypercapnia. Ann Emergency Med 1994; 24: 701-3.
109 Edwards G, Leszczynski SO. A double blind trial of five respiratory stimulants in patients in acute ventilatory failure. Lancet 1967; i: 226-9.
110 Riordan JF, Sillett RW, McNichol MW. A controlled trial of doxapram in acute respiratory failure. Br J Dis Chest 1975; 69:57-62.
111 Moser KM, Luchsinger PC, Adamson JS et al. Respiratory stimulation with intravenous doxapram in respiratory failure: a double-blind co-operative study. N Engl J Med 1973; 288: 427-31.
112 Angus RM, Ahmed AA, Fenwick LJ, Peacock AJ. Comparison of acute effects on gas exchange of nasal ventilation and doxapram in exacerbation of chronic obstructive pulmonary disease. Thorax 1996; 51: 1048-50.
113 Powles AC, Tuxen DV, Mahood CB, Pugsley SO, Campbell EJ. The effect of intravenously administered almitrine, a peripheral chemoreceptor agonist, on patients with chronic air-flow obstruction. Am Rev Respir Dis 1983; 127: 284-9.
114 Marcq M, Gepts L, Erven W, Minette A. [Effect of almitrine on arterial gases in patients with chronic respiratory insufficiency: comparison with doxapram—preliminary results.] Rev InstHygMines (Hasselt) 1979; 34: 141-9.
115 Bardsley PA, Tweney J, Morgan N, Howard P. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease. Thorax 1991; 46: 493-8.
Was this article helpful?